[Methotrexate: advantages of subcutaneous administration].
Krüger
K
K
Praxiszentrum St. Bonifatius, St. Bonifatius Strasse 5, 81541 München, Deutschland. klaus.krueger@med.uni-muenchen
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects*; D008875:Middle Aged; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D008727:Methotrexate